Randall Broyles

Chief Strategy Officer (cso) at CSI Pharmacy

Randall Broyles has a strong background in pharmacy operations and leadership. Randall is currently working as the Chief Operations Officer at CSI Pharmacy. Prior to that, they held the role of Vice President, Pharmacy Operations at Optum, where they managed all operational aspects of a home infusion pharmacy and provided leadership and oversight for 59 pharmacy sites. Before that, Broyles served as the Vice President, Operations at Diplomat Specialty Infusion Group, where they led all operational and administrative aspects of a specialty infusion pharmacy and successfully launched multiple programs. Randall also has experience as a General Manager at Walgreens Infusion Pharmacy and as the Director of Pharmacy Development at Curascript Infusion Pharmacy. At Integrity Healthcare Services, Broyles served as the Regional Pharmacy Director, managing multiple infusion sites and ensuring compliance with industry standards. Overall, Broyles has a proven track record of successfully managing pharmacy operations and leading teams.

Randall Broyles holds a Bachelor of Science degree in Pharmacy Management from The Ohio State University. No specific start or end years are mentioned.

Location

Cincinnati, United States

Links


Org chart


Teams


Offices

This person is not in any offices


CSI Pharmacy

At Clinical Specialty Infusions (CSI Pharmacy), we are committed to making sure every patient receives the care she or he needs, whether or not you are our client. CSI Pharmacy provides infusion therapy in the home. Over the past few years, CSI Pharmacy has grown from a small, hometown pharmacy into a thriving nationwide specialty pharmacy with two physical locations and plans for more. Our team of expert clinicians, passionate advocates, committed healthcare partners, and strategic reimbursement experts works to develop relationships with individuals who live with rare, debilitating diseases. Patient communities include those with chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, myasthenia gravis, myositis, pemphigus/pemphigoid, Huntington’s disease, primary immune deficiency diseases, and others who require immune globulin therapy and other highly specialized treatments. The people we serve are so much more than patients; they are members of our family.


Industries

Employees

51-200

Links